Fidelity Covington Trust - Fidelity MSCI Health Care Index ETF

This powerful committee controls taxation, trade, and entitlement spending. It directly impacts healthcare through Medicare pricing, which is a major revenue determinant for pharmaceutical companies, hospitals, and insurers, and also influences corporate tax policy for all companies in the sector.

This committee allocates discretionary federal spending. Its subcommittees determine the precise funding levels for critical areas like medical research (NIH), public health initiatives (CDC), and various federal healthcare programs, directly affecting healthcare companies' revenue streams and R&D.

This is a primary regulatory body for the healthcare sector, directly overseeing the FDA (drug and device approval), NIH (medical research funding), and influencing labor laws that affect healthcare providers and their costs.

This committee's oversight of antitrust laws directly impacts mergers and acquisitions in the healthcare industry, and its role in intellectual property protection is fundamental to the business models of pharmaceutical and medical device companies.

This committee directly impacts the healthcare sector by investigating issues like drug pricing and long-term care quality, which are major drivers of revenue and costs for pharmaceutical and healthcare service companies, creating significant 'headline risk'.

This committee directly impacts government healthcare contractors and medical device manufacturers by overseeing the Department of Veterans Affairs and its significant healthcare funding and procurement decisions.